Between February 19, 2020 and June 22, 2021, 62 patients with metastatic MSS colorectal cancer were screened for MGMT promoter hypermethylation, of which 51 had adequate tumor tissue for clinical grade MGMT testing by bisulfite deamination and MS-PCR. The gene discussed is MGMT; the disease is colorectal cancer.